Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DL-Borneol ((endo)-Borneol) 是一种从中药中提取的小分子,是一种可口服的生物佐剂,可以改善药物向大脑的输送,常用作治疗心脑血管疾病的中药的辅助成分。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
50 mg | ¥ 278 | 现货 | ||
100 mg | ¥ 397 | 现货 | ||
500 mg | ¥ 1,290 | 现货 |
产品描述 | DL-Borneol ((endo)-Borneol) is a small molecule extracted from traditional Chinese medicine (TCM). It is an orally bioadjuvant that improves drug delivery to the brain and is commonly used as an adjuvant ingredient in TCM for the treatment of cardio-cerebral vascular diseases. |
靶点活性 | 26S:157±19 μM, 20S:118.8±15.7 μM |
体外活性 | In vitro, Borneol enhances the intracellular accumulation of Rho123 and facilitates the transport of P-gp substrates across the blood-brain barrier (BBB). Additionally, it downregulates the expression of mdr1a mRNA and P-gp. Borneol activates NF-κB, and the inhibition of NF-κB with MG132 and SN50 attenuates the reduction in P-gp induced by Borneol. Treatment with 10 μg/mL and 20 μg/mL Borneol transiently increases the phosphorylation of IκB expression at 30 min post-treatment. Furthermore, Borneol treatment leads to a decrease in P-gp expression in brain microvascular endothelial cells (BMECs)[1]. |
体内活性 | Borneol significantly counteracts the process of epileptogenesis in PTZ-kindled mice. Borneol-treated animals show amelioration of biochemical alterations induced by PTZ kindling, as evidenced by decreased lipid peroxidation (LPO) and increased levels of superoxide dismutase (SOD), glutathione (GSH), and catalase (CAT). The distinct neuronal damage observed in the kindled group is suppressed by Borneol. Additionally, Borneol reduces the levels of GFAP, as indicated by reduced immunostaining[3]. The pharmacokinetic traits of Borneol are significantly affected by the pathological damages of ischemia-reperfusion, and there are components in Xingnaojing that inhibit the absorption of Borneol[2]. |
别名 | (endo)-Borneol, Borneol, (±)-Borneol |
分子量 | 154.25 |
分子式 | C10H18O |
CAS No. | 507-70-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 30 mg/mL (259.32 mM), Sonication is recommended.
H2O: <0.1 mg/mL (Insoluble)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 6.483 mL | 32.4149 mL | 64.8298 mL | 162.0746 mL |
5 mM | 1.2966 mL | 6.483 mL | 12.966 mL | 32.4149 mL | |
10 mM | 0.6483 mL | 3.2415 mL | 6.483 mL | 16.2075 mL | |
20 mM | 0.3241 mL | 1.6207 mL | 3.2415 mL | 8.1037 mL | |
50 mM | 0.1297 mL | 0.6483 mL | 1.2966 mL | 3.2415 mL | |
100 mM | 0.0648 mL | 0.3241 mL | 0.6483 mL | 1.6207 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
DL-Borneol 507-70-0 Membrane transporter/Ion channel Metabolism Neuroscience GABA Receptor Endogenous Metabolite (endo)-Borneol Borneol (±)-Borneol Inhibitor inhibitor inhibit